Cardiac allograft vasculopathy epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
As per the data from the Registry of the International Society of Heart and Lung transplantation<ref name="pmid17692781">{{cite journal| author=Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J et al.| title=Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007. | journal=J Heart Lung Transplant | year= 2007 | volume= 26 | issue= 8 | pages= 769-81 | pmid=17692781 | doi=10.1016/j.healun.2007.06.004 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17692781 }} </ref>, the number of reported heart transplants has increased slowly in the recent years, especially in North America. | As per the data from the Registry of the International Society of Heart and Lung transplantation<ref name="pmid17692781">{{cite journal| author=Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J et al.| title=Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007. | journal=J Heart Lung Transplant | year= 2007 | volume= 26 | issue= 8 | pages= 769-81 | pmid=17692781 | doi=10.1016/j.healun.2007.06.004 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17692781 }} </ref>, the number of reported heart transplants has increased slowly in the recent years, especially in North America. The overall prevalence of CAV in post-cardiac transplant patients in the registry at 1, 5 and 10 years is 8, 30 and 50% respectively. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 21:10, 29 September 2014
|
Cardiac allograft vasculopathy Microchapters |
|
Differentiating Cardiac allograft vasculopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cardiac allograft vasculopathy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cardiac allograft vasculopathy epidemiology and demographics |
|
FDA on Cardiac allograft vasculopathy epidemiology and demographics |
|
CDC on Cardiac allograft vasculopathy epidemiology and demographics |
|
Cardiac allograft vasculopathy epidemiology and demographics in the news |
|
Blogs on Cardiac allograft vasculopathy epidemiology and demographics |
|
Directions to Hospitals Treating Cardiac allograft vasculopathy |
|
Risk calculators and risk factors for Cardiac allograft vasculopathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]
Overview
As per the data from the Registry of the International Society of Heart and Lung transplantation[1], the number of reported heart transplants has increased slowly in the recent years, especially in North America. The overall prevalence of CAV in post-cardiac transplant patients in the registry at 1, 5 and 10 years is 8, 30 and 50% respectively.
Epidemiology and Demographics
A review of United Network of Organ Sharing (UNOS) heart transplant database was performed by Nagji and colleagues in 2010 [2].
References
- ↑ Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J; et al. (2007). "Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007". J Heart Lung Transplant. 26 (8): 769–81. doi:10.1016/j.healun.2007.06.004. PMID 17692781.
- ↑ Nagji AS, Hranjec T, Swenson BR, Kern JA, Bergin JD, Jones DR; et al. (2010). "Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: implications for donor allocation". Ann Thorac Surg. 90 (1): 168–75. doi:10.1016/j.athoracsur.2010.03.043. PMC 3033784. PMID 20609769.